Cite
HARVARD Citation
Yiu, T. et al. (n.d.). P564 vedolizumab versus infliximab and adalimumab in the real-world persistence in Ulcerative Colitis and Crohn's disease – a meta-analysis. Journal of Crohn's and colitis. pp. i694-i695. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yiu, T. et al. (n.d.). P564 vedolizumab versus infliximab and adalimumab in the real-world persistence in Ulcerative Colitis and Crohn's disease – a meta-analysis. Journal of Crohn's and colitis. pp. i694-i695. [Online].